急性心肌梗死后非心血管疾病负担与死亡的时间趋势
丹麦全国性注册队列纳入2000至2017年136,293例心肌梗死患者,1年心血管死亡率由18.4%降至7.6%,非心血管死亡率由5.8%降至5.0%,但非心血管死亡占总死亡比例由24.1%升至39.5%,且癌症、肾病和感染风险上升。
要点
- 心梗后心血管死亡率大幅下降,但非心血管死亡占比升至39.5%。
- 1年癌症、肾病和感染风险均呈上升趋势(P趋势<0.01)。
- 患者特征标准化后癌症风险增加不再显著,肾病和感染仍显著。
核心结论
- 2000至2017年丹麦心梗患者心血管死亡率显著改善,但非心血管疾病发病风险增加且非心血管原因占心梗后死亡比例上升。
研究设计与样本
- 基于注册的全国性队列研究,纳入2000至2017年丹麦所有心肌梗死患者136,293例(63.2%为男性,中位年龄69岁)。
主要发现
- 2000至2002年与2015至2017年相比,1年心血管死亡率由18.4%降至7.6%,非心血管死亡率由5.8%降至5.0%。
- 非心血管原因占总1年死亡的比例由24.1%升至39.5%。
- 1年癌症风险由1.9%升至2.4%,肾病由1.0%升至1.6%,感染性疾病由5.5%升至9.1%(所有P趋势<0.01)。
- 患者特征标准化后,2015至2017年较2000至2002年癌症风险增加不再显著(标准化风险比0.99,95%CI 0.91-1.07),肾病为1.28(95%CI 1.15-1.41),感染性疾病为1.28(95%CI 1.23-1.34)。
临床怎么用
- 心梗后管理除关注心血管结局外,应重视非心血管疾病(尤其肾病和感染)的监测与防治。
- 指南和未来临床试验设计应考虑将非心血管结局纳入评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Due to improved management, diagnosis, and care of myocardial infarction (MI), patients may now survive long enough to increasingly develop serious noncardiovascular conditions. OBJECTIVES: This study aimed to test this hypothesis by investigating the temporal trends in noncardiovascular morbidity and mortality following MI. METHODS: We conducted a registry-based nationwide cohort study of all Danish patients with MI during 2000 to 2017. Outcomes were cardiovascular and noncardiovascular mortality, incident cancer, incident renal disease, and severe infectious disease. RESULTS: From 2000 to 2017, 136,293 consecutive patients were identified (63.2% men, median age 69 years). The 1-year risk of cardiovascular mortality between 2000 to 2002 and 2015 to 2017 decreased from 18.4% to 7.6%, whereas noncardiovascular mortality decreased from 5.8% to 5.0%. This corresponded to an increase in the proportion of total 1-year mortality attributed to noncardiovascular causes from 24.1% to 39.5%. Furthermore, increases in 1-year risk of incident cancer (1.9%-2.4%), incident renal disease (1.0%-1.6%), and infectious disease (5.5%-9.1%) were observed (all P trend <0.01). In analyses standardized for changes in patient characteristics, the increased risk of cancer in 2015 to 2017 compared with 2000 to 2002 was no longer significant (standardized risk ratios for cancer: 0.99 [95% CI: 0.91-1.07]; renal disease: 1.28 [95% CI: 1.15-1.41]; infectious disease: 1.28 [95% CI: 1.23-1.34]). CONCLUSIONS: Although cardiovascular mortality following MI improved substantially during 2000 to 2017, the risk of noncardiovascular morbidity increased. Moreover, noncardiovascular causes constitute an increasing proportion of post-MI mortality. These findings suggest that further attention on noncardiovascular outcomes is warranted in guidelines and clinical practice and should be considered in the design of future clinical trials.
引用
- Christensen DM, Strange JE, El-Chouli M, et al. Temporal Trends in Noncardiovascular Morbidity and Mortality Following Acute Myocardial Infarction. J Am Coll Cardiol. 2023. PMID: 37648355. doi:10.1016/j.jacc.2023.06.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。